Thumbnail Image
Publication

Enhanced growth-inhibitory effect of microemulsified curcumin formulation in human prostate cancer LNCaP Cells

Dubey, Vaibhav
; 
Owusu-Apenten, Richard K.
Advisors
Editors
Other Contributors
Affiliation
University of Chester, University of Ulster
EPub Date
Publication Date
2015-01-01
Submitted Date
Collections
Clinical Sciences and Nutrition
Show all metadata
Files
Thumbnail Image
Main article
Adobe PDF, 324.53 KB
Other Titles
Abstract
Aim: To assess the effect of curcumin microemulsified with non-ionic surfactant surfynol 465 W or dispersed using edible oils on prostate LNCaP cancer cell viability and glutathione status. Methodology: LNCaP cells were treated for 72-144 hr with curcumin dissolved with fish or corn oil and microemulsified using non-ionic surfactant surfynol 465 W; alternatively LNCaP cells were treated with curcumin directly dispersed in fish or corn oil (0-50 μM) for 24 -72-144 hr. Cell viability was determined using resazurin (Vision blueTM) fluorescence assay. Glutathione status was determined by monochlorobimane (MCB) assay. Results: Treatment with 0-34 μM of microemulsified curcumin produced moderate cytotoxic effect on LNCaP cells, no 50% reduction of cell viability was observed graphically. However, when LNCaP cells were treated with curcumin dispersed with corn oil the concentration or 50% reduction of cell viability (IC50) was 12-45 μM. Similarly for cells treated with curcumin dispersed with fish oil, the IC50 was between 20-40 μM. Cytotoxic doses of curcumin dispersed with corn or fish oil increased GST status in cells by 272-656% (p =<0.01). Conclusion: Microemulsified curcumin formulation prepared using fish or corn oil and surfynol 465 W surfactant had an inhibitory effect on viability of LNCaP cells as did direct dispersion of curcumin in fish or corn oil coupled with the ability for inducing intracellular GST status in LNCaP cells.
Citation
Dubey, V., & Owusu-Apenten, R. (2015). Enhanced growth-inhibitory effect of microemulsified curcumin formulation in human prostate cancer LNCaP Cells. British Journal of Pharmaceutical Research, 5(3), 209-216.
Publisher
SCIENCEDOMAIN International
Journal
British Journal of Pharmaceutical Research
Research Unit
URI
http://hdl.handle.net/10034/621909
DOI
10.9734/BJPR/2015/14475
PubMed ID
PubMed Central ID
Type
Article
Language
en
Description
Series/Report no.
ISSN
2231-2919
EISSN
2231-2919
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
Additional Links
http://www.sciencedomain.org/abstract/7465